Celgene Corporation operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Celgene with three other
companies in this sector in the United States:
sales of $9.43 billion
of which 87%
Shire Plc - adr
of which 100%
was Pharmaceuticals & Genetic Therapies), and
Perrigo Company PLC
of which 50%
was Consumer Healthcare).
Celgene reported sales of $9.26 billion
December of 2015.
increase of 20.7%
versus 2014, when the company's sales were $7.67 billion.
Sales at Celgene have increased during each of the previous five years
(and since 2010, sales have increased a total of 159%).